DCGI clears Covid-19 vaccines Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin for restricted use in emergency

Drugs Controller General of India, DCGI has given approval for restricted use in emergency situation of two Covid19 vaccines- Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin. The announcement for granting permission to these two vaccines was made by the Drug Controller General of India VG Somani during a press conference.

COVISHIELD has been developed at the Serum Institute of India’s Pune laboratory with a master seed from Oxford University and AstraZeneca. Drug Controller General of India VG Somani said both firms submitted data on their trial runs and both have been granted permission for restricted use. Mr Somani said. DCGI will never approve anything if there is slightest of safety concern.

The vaccines are 100 percent safe. The DCGI said, the Central Drugs Standard Control Organisation (CDSCO) gave its approval followed by the recommendation of the Subject Expert Committee (SEC) that recommended both the vaccines for emergency use.